Physician profile
David M Walker
NPI 1326028770
$8,136.63
in general payments reported to CMS, 2019-2025
57 companies · $1,442 in 2025
The $1,442 reported for 2025 was more than what 91% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,115 · 2020: $915 · 2021: $1,053 · 2022: $1,342 · 2023: $898 · 2024: $1,371 · 2025: $1,442.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,710.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,710.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,057.91 | 2020-2025 | Ubrelvy, Vraylar, Linzess |
| Novo Nordisk INC | $930.25 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $664.15 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Lilly USA, LLC | $510.87 | 2019-2025 | Zepbound, Mounjaro, Jardiance |
| Pfizer INC. | $447.25 | 2019-2025 | |
| Amgen INC. | $393.04 | 2019-2025 | Evenity, Prolia, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $378.56 | 2019-2025 | Jardiance |
| Glaxosmithkline, LLC. | $336.32 | 2019-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Amarin Pharma, INC. | $261.61 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $258.76 | 2019-2024 | Xarelto, Spravato |
| Sanofi-Aventis U.S. LLC | $257.60 | 2019-2023 | |
| Exact Sciences Corporation | $225.09 | 2023-2025 | Cologuard Collection Kit |
| Astellas Pharma US INC | $184.75 | 2019-2025 | Veozah |
| Abbott Laboratories | $171.98 | 2021-2024 | Freestyle Libre 3, Freestyle Libre 2 |
| Bayer Healthcare Pharmaceuticals INC. | $170.91 | 2021-2025 |
Show all 57 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.